RASHMEE POKHAREL: Open Payments
NPI 1053786640 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 44 payments from 23 companies in 2025. Trend: 2023 $34 · 2024 $24 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $175 |
| Radius Health, Inc. | 4 | $128 |
| Amgen Inc. | 5 | $118 |
| Madrigal Pharmaceuticals | 3 | $106 |
| Ascendis Pharma Endocrinology Inc | 3 | $80 |
| Corcept Therapeutics | 4 | $78 |
| SANOFI-AVENTIS U.S. LLC | 3 | $73 |
| Novo Nordisk Inc | 3 | $59 |
| Stryker Corporation | 1 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
Products named: CeQur Simplicity, REZDIFFRA, TEPEZZA, Yorvipath, Korlym, TZIELD, Ozempic, FLOWTRIEVER CATHETER, S.
Industry payments across FL — which companies pay providers there.
